Ali Al-Ameri1, Puneet Malhotra2, Helene Thygesen3, Paul K Plant4, Sri Vaidyanathan5, Shishir Karthik5, Andrew Scarsbrook5, Matthew E J Callister6. 1. Department of Respiratory Medicine, Pinderfields General Hospital, Wakefield, UK. 2. Department of Respiratory Medicine, Whiston Hospital, Liverpool, UK. 3. Department of Biostatistical Support, Cancer Research UK Leeds Centre, Leeds, UK. 4. Department of Respiratory Medicine, North Cumbria University Hospitals, Carlisle, UK. 5. Department of Radiology, Leeds Teaching Hospitals, Leeds, UK. 6. Department of Respiratory Medicine, Leeds Teaching Hospitals, Leeds, UK. Electronic address: matthew.callister@nhs.net.
Abstract
OBJECTIVES: Clinical prediction models assess the likelihood of malignancy in pulmonary nodules detected by computed tomography (CT). This study aimed to validate four such models in a UK population of patients with pulmonary nodules. Three models used clinical and CT characteristics to predict risk (Mayo Clinic, Veterans Association, Brock University) with a fourth model (Herder et al. [4]) additionally incorporating (18)Fluorine-Fluorodeoxyglucose (FDG) avidity on positron emission tomography-computed tomography (PET-CT). MATERIALS AND METHODS: The likelihood of malignancy was calculated for patients with pulmonary nodules (4-30mm diameter) and data used to calculate the area under the receiver operating characteristic curve (AUC) for each model. The models were used in a restricted cohort of patients based on each model's exclusion criteria and in the total cohort of all patients. RESULTS: Two hundred and forty-four patients were studied, of whom 139 underwent FDG PET-CT. Ninety-nine (40.6%) patients were subsequently confirmed to have malignant nodules (33.2% primary lung cancer, 7.4% metastatic disease). The Mayo and Brock models performed similarly (AUC 0.895 and 0.902 respectively) and both were significantly better than the Veterans Association model (AUC 0.735, p<0.001 and p=0.002 respectively). In patients undergoing FDG PET-CT, the Herder model had significantly higher accuracy than the other three models (AUC 0.924). When the models were tested on all patients in the cohort (i.e. including those outside the original model inclusion criteria) AUC values were reduced, yet remained high especially for the Herder model (AUC 0.916). For sub-centimetre nodules, AUC values for the Mayo and Brock models were 0.788 and 0.852 respectively. CONCLUSIONS: The Mayo and Brock models showed good accuracy for determining likelihood of malignancy in nodules detected on CT scan. In patients undergoing FDG PET-CT for nodule evaluation, the highest accuracy was seen for the model described by Herder et al. incorporating FDG avidity.
OBJECTIVES: Clinical prediction models assess the likelihood of malignancy in pulmonary nodules detected by computed tomography (CT). This study aimed to validate four such models in a UK population of patients with pulmonary nodules. Three models used clinical and CT characteristics to predict risk (Mayo Clinic, Veterans Association, Brock University) with a fourth model (Herder et al. [4]) additionally incorporating (18)Fluorine-Fluorodeoxyglucose (FDG) avidity on positron emission tomography-computed tomography (PET-CT). MATERIALS AND METHODS: The likelihood of malignancy was calculated for patients with pulmonary nodules (4-30mm diameter) and data used to calculate the area under the receiver operating characteristic curve (AUC) for each model. The models were used in a restricted cohort of patients based on each model's exclusion criteria and in the total cohort of all patients. RESULTS: Two hundred and forty-four patients were studied, of whom 139 underwent FDG PET-CT. Ninety-nine (40.6%) patients were subsequently confirmed to have malignant nodules (33.2% primary lung cancer, 7.4% metastatic disease). The Mayo and Brock models performed similarly (AUC 0.895 and 0.902 respectively) and both were significantly better than the Veterans Association model (AUC 0.735, p<0.001 and p=0.002 respectively). In patients undergoing FDG PET-CT, the Herder model had significantly higher accuracy than the other three models (AUC 0.924). When the models were tested on all patients in the cohort (i.e. including those outside the original model inclusion criteria) AUC values were reduced, yet remained high especially for the Herder model (AUC 0.916). For sub-centimetre nodules, AUC values for the Mayo and Brock models were 0.788 and 0.852 respectively. CONCLUSIONS: The Mayo and Brock models showed good accuracy for determining likelihood of malignancy in nodules detected on CT scan. In patients undergoing FDG PET-CT for nodule evaluation, the highest accuracy was seen for the model described by Herder et al. incorporating FDG avidity.
Authors: Marco Spadafora; Leonardo Pace; Laura Evangelista; Luigi Mansi; Francesco Del Prete; Giorgio Saladini; Paolo Miletto; Stefano Fanti; Silvana Del Vecchio; Luca Guerra; Giovanna Pepe; Giuseppina Peluso; Emanuele Nicolai; Giovanni Storto; Marco Ferdeghini; Alessandro Giordano; Mohsen Farsad; Orazio Schillaci; Cesare Gridelli; Alberto Cuocolo Journal: Eur J Nucl Med Mol Imaging Date: 2018-05-05 Impact factor: 9.236
Authors: Johanna Uthoff; Nicholas Koehn; Jared Larson; Samantha K N Dilger; Emily Hammond; Ann Schwartz; Brian Mullan; Rolando Sanchez; Richard M Hoffman; Jessica C Sieren Journal: Eur Radiol Date: 2019-04-01 Impact factor: 5.315
Authors: Simone Perandini; G A Soardi; A R Larici; A Del Ciello; G Rizzardi; A Solazzo; L Mancino; F Zeraj; M Bernhart; M Signorini; M Motton; S Montemezzi Journal: Eur Radiol Date: 2016-09-15 Impact factor: 5.315
Authors: Wei Wu; Larry A Pierce; Yuzheng Zhang; Sudhakar N J Pipavath; Timothy W Randolph; Kristin J Lastwika; Paul D Lampe; A McGarry Houghton; Haining Liu; Liming Xia; Paul E Kinahan Journal: Eur Radiol Date: 2019-05-21 Impact factor: 5.315